IRIS
IEZZI, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.455
EU - Europa 3.820
AS - Asia 2.423
SA - Sud America 208
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 5
Totale 10.942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.432
SG - Singapore 872
IT - Italia 757
CN - Cina 729
IE - Irlanda 706
UA - Ucraina 602
SE - Svezia 477
TR - Turchia 468
GB - Regno Unito 363
DE - Germania 266
FR - Francia 259
IN - India 245
BR - Brasile 191
FI - Finlandia 132
RU - Federazione Russa 107
NL - Olanda 42
CZ - Repubblica Ceca 38
VN - Vietnam 32
BE - Belgio 28
HK - Hong Kong 27
AT - Austria 18
CA - Canada 13
IR - Iran 13
EU - Europa 12
GR - Grecia 7
IL - Israele 5
MA - Marocco 5
BZ - Belize 4
CL - Cile 4
IQ - Iraq 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
AU - Australia 3
BD - Bangladesh 3
CH - Svizzera 3
EG - Egitto 3
MY - Malesia 3
PT - Portogallo 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AO - Angola 2
CO - Colombia 2
JM - Giamaica 2
JP - Giappone 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PL - Polonia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
ID - Indonesia 1
KE - Kenya 1
LB - Libano 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
SN - Senegal 1
UY - Uruguay 1
Totale 10.942
Salva come PNG Salva come JPEG
Città #
Chandler 896
Jacksonville 704
Dublin 696
Singapore 593
Princeton 300
Southend 286
Dearborn 233
Izmir 225
Nanjing 184
Ann Arbor 155
Beijing 149
Ashburn 143
Altamura 134
Wilmington 134
Santa Clara 123
Chieti 121
Cambridge 111
The Dalles 107
Boardman 98
Pescara 95
New York 85
Nanchang 63
Woodbridge 50
Los Angeles 38
Hebei 34
Helsinki 34
Grevenbroich 33
Dong Ket 31
Tianjin 30
Washington 30
Shenyang 29
Brno 28
Hong Kong 26
Kunming 24
Nuremberg 24
Rome 24
Brussels 23
Norwalk 23
Changsha 21
Seattle 21
Ancona 20
Jiaxing 18
Milan 17
Castignano 16
Hangzhou 16
Jinan 16
San Mateo 16
Munich 15
Amsterdam 14
Augusta 14
Orange 14
Falls Church 13
London 13
São Paulo 13
Camerino 12
Frankfurt am Main 12
Houston 12
Vienna 12
Guangzhou 11
Leawood 11
Pune 11
Ascoli Piceno 10
Chicago 10
Toronto 10
Ardabil 9
Bologna 9
Changchun 9
Hefei 9
Lanzhou 9
Napoli 9
Rio de Janeiro 9
Verona 9
Collecorvino 7
Olomouc 7
Senigallia 7
Zhengzhou 7
Düsseldorf 6
Romola 6
Rouen 6
Saint-Saens 6
Taizhou 6
Bari 5
Belo Horizonte 5
Guarulhos 5
Istanbul 5
Lappeenranta 5
Monmouth Junction 5
San Giovanni 5
Tappahannock 5
Torino 5
Andover 4
Brasília 4
Curitiba 4
Fuzhou 4
Jülich 4
L'aquila 4
Palermo 4
Redwood City 4
San Benedetto del Tronto 4
San Diego 4
Totale 6.699
Salva come PNG Salva come JPEG
Nome #
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 137
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 136
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 130
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 126
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 118
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 114
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 111
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 110
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 105
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 105
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 105
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 104
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 99
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 99
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 99
L’allergoide monomerico agisce anche sul GALT 99
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 97
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 97
Anti-Thyroid Effect of Resveratrol 96
Resveratrol has anti-thyroid effects both in vitro and in vivo 96
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 95
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 95
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 94
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 94
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 94
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 94
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 94
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 93
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 93
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 93
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 92
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 91
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 91
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 91
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 90
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 90
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 90
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 90
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 89
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 89
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 89
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 89
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 87
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 87
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 87
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 87
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 87
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 86
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 86
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 86
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 85
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 85
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 84
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 84
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 83
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 82
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 81
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 81
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 80
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 80
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 80
Inhibition of the Phosphatidylinositol 3-kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects. 80
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 79
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 79
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 79
Neutrophils in anti-cancer immunological strategies: old players in new games 78
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 78
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 78
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 78
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 77
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 77
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 76
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 76
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 75
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 75
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 75
Antimetastatic activity of a preventive cancer vaccine. 75
Stem Cell Emergence After HBO In Volunteers 75
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment 75
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 75
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 74
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 74
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 74
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 74
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 73
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 72
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 72
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 72
Phospholipase Cgamma1 is required for metastasis development and progression 71
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 71
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 71
p130Cas is an essential transducer element in ErbB2 transformation. 71
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 71
rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant. 70
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 70
Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice. 69
Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma. 69
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 69
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 69
Triggering CD40 on endothelial cells contributes to tumor growth. 68
Totale 8.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020189 0 0 0 0 0 0 0 0 0 0 166 23
2020/2021932 135 17 150 12 88 165 27 10 58 115 90 65
2021/2022708 14 14 14 120 53 12 26 60 55 50 83 207
2022/20232.468 184 362 156 280 272 471 127 168 285 32 63 68
2023/20241.158 78 54 68 51 61 346 270 66 14 28 13 109
2024/20252.283 173 490 388 102 94 136 205 194 294 130 77 0
Totale 11.497